Clearwater has advised IDI, a leading French private equity firm with 50 years of experience, on raising debt finance to support the acquisition of Prévost Laboratory Concept, a laboratory and manufacturer of cosmetic products and food supplements (CDMO), from Abenex and Arkéa Capital. This transaction enables IDI to acquire a majority stake in Prévost Laboratory Concept, alongside the management team led by Marc-Henry Lussigny.
Founded in 1992, Prévost Laboratory Concept has established itself as a specialist in the formulation, regulatory compliance, production, and packaging of liquid and semi-liquid cosmetic products and food supplements. The group boasts a loyal base of over 200 active customers, mainly consisting of young, fast-growing, independent French brands. With recognised expertise in R&D and formulation, the group offers product innovations, an agile production facility capable of handling small and medium-sized production runs, and a sales drive led by CEO Marc-Henry Lussigny since his arrival three years ago.
Furthermore, Prévost Laboratory Concept's CSR policy and its offerings tailored to today's environmental challenges, with 50% of formulas composed of over 95% natural ingredients, align with IDI's commitment to placing ESG issues at the heart of its strategy by supporting socially responsible entities.
In the coming years, IDI plans to transform Prévost Laboratory Concept into an active platform for market consolidation, notably by acquiring complementary know-how to expand its product ranges.
